Impact of food and water-borne diseases on European population health

Current Opinion in Food Science

Volumn 12, Issue , 2016, Pages 21-29

  Cassini, A ^a,b   Colzani, E ^a,c   Kramarz, P ^a   Kretzschmar, M E ^b,d   Takkinen, J ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977480894     PISSN: 22147993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cofs.2016.06.002     Document Type: Review

References (57)

1. Mølbak K., Simonsen J., Jørgensen C.S., Krogfelt K.A., Falkenhorst G., Ethelberg S., et al. Seroincidence of human infections with nontyphoid Salmonella compared with data from public health surveillance and food animals in 13 European countries. Clin Infect Dis 2014, 59:1599-1606.
2. Teunis P.F., Falkenhorst G., Ang C.W., Strid M.A., De Valk H., Sadkowska-Todys M., et al. Campylobacter seroconversion rates in selected countries in the European Union. Epidemiol Infect 2013, 141:2051-2057.
3. Emborg H.D., Teunis P., Simonsen J., Krogfelt K.A., Jorgensen C.S., Takkinen J., et al. Was the increase in culture-confirmed Campylobacter infections in Denmark during the 1990s a surveillance artefact?. Euro Surveill 2015, 20.
4. EFSA (European Food Safety Authority) and ECDC (European Centre for Disease Prevention and Control) The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2014. EFSA J 2015, 12:191.
5. Murray C.J., Ezzati M., Flaxman A.D., Lim S., Lozano R., Michaud C., et al. GBD 2010: design, definitions, and metrics. Lancet 2012, 380:2063-2066.
6. Havelaar A.H., Haagsma J.A., Mangen M.J., Kemmeren J.M., Verhoef L.P., Vijgen S.M., et al. Disease burden of foodborne pathogens in the Netherlands, 2009. Int J Food Microbiol 2012, 156:231-238.
7. Gkogka E., Reij M.W., Havelaar A.H., Zwietering M.H., Gorris L.G. Risk-based estimate of effect of foodborne diseases on public health, Greece. Emerg Infect Dis 2011, 17:1581-1590.
8. Batz M.B., Hoffmann S., Morris J.G. Ranking the risks: The 10 pathogen-food combinations with the greatest burden on public health 2011, Emerging Pathogens Institute, University of Florida, Gainesville, FL.
9. Bijkerk P., van Lier A., McDonald S., Kardamanidis K., Fanoy E.B., Wallinga J., et al. State of infectious diseases in the Netherlands, 2013 2014, National Institute for Public Health and the Environment, RIVM, Bilthoven, The Netherlands.
10. Global Burden of Disease Study C Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:743-800.
11. Oostvogels A.J., De Wit G.A., Jahn B., Cassini A., Colzani E., De Waure C., et al. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol Infect 2015, 143:1791-1802.
12. van Lier E.A., Havelaar A.H., Nanda A. The burden of infectious diseases in Europe: a pilot study. Euro Surveill 2007, 12:E3-E4.
13. Jakab Z. Why a burden of disease study?. Euro Surveill 2007, 12:E1-E2.
14. Kretzschmar M., Mangen M.J., Pinheiro P., Jahn B., Fevre E.M., Longhi S., et al. New methodology for estimating the burden of infectious diseases in Europe. PLoS Med 2012, 9:e1001205.
15. Mangen M.J., Plass D., Havelaar A.H., Gibbons C.L., Cassini A., Muhlberger N., et al. The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases. PLOS ONE 2013, 8:e79740.
16. Colzani E. Results from the 2015 Burden of Communicable Diseases in Europe (BCoDE) study. European public health conference 2015.
17. Cassini A.C.E., Pini A., Maringhini G., Mangen M.J.J., Plass D., et al. Impact of infectious diseases in the European Union and European Economic Area: results from the Burden of Communicable Diseases in Europe (BCoDE) 2015 study 2016, [in preparation].
18. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden Of Disease Study. Lancet 1997, 349:1436-1442.
19. European Parliament Council DECISION No 1082/2013/EU of 22 October 2013 on serious cross-border threats to health and repealing Decision No 2119/98/EC 2013, Official Journal of the European Union, Strasbourg.
20. The European Surveillance System: European Centre for Disease Prevention and Control.
21. ECDC BCoDE toolkit [software, application] 2015, European Centre for Disease Prevention and Control, Stockholm. 1.2 ed.
22. Colzani E., Cassini A.L.D., Mangen M.J.J., Plass D., McDonald S.A., et al. Improving the usability and communicability of burden of disease methods and outputs: the BCoDE toolkit. Lancet 2016, 381.
23. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
24. GBD 2013 DALYs and HALE Collaborators, Murray C.J., Barber R.M., Foreman K.J., Abbasoglu Ozgoren A., Abd-Allah F., et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015, 386:2145-2191.
25. Murray C.L.A., Rethinking DALYs. The Global Burden Of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, World Health Organization.
26. Schroeder S.A. Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life years. Popul Health Metr 2012, 10:19.
27. Mangen M.J.J., Plass D., Kretzschmar M.E. Estimating the current and future burden of communicable diseases in the European Union and EEA/EFTA 2014, [Section 2.4.3], National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
28. Haagsma J.A., Polinder S., Cassini A., Colzani E., Havelaar A.H. Review of disability weight studies: comparison of methodological choices and values. Popul Health Metr 2014, 12:20.
29. Haagsma J.A., Maertens de Noordhout C., Polinder S., Vos T., Havelaar A.H., Cassini A., et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr 2015, 13:10.
30. Salomon J.A., Haagsma J.A., Davis A., de Noordhout C.M., Polinder S., Havelaar A.H., et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 2015, 3:e712-e723.
31. Anand S., Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997, 16:685-702.
32. Gibbons C.L., Mangen M.J., Plass D., Havelaar A.H., Brooke R.J., Kramarz P., et al. Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health 2014, 14:147.
33. Stein C.E., Birmingham M., Kurian M., Duclos P., Strebel P. The global burden of measles in the year 2000 - a model that uses country-specific indicators. J Infect Dis 2003, 187(Suppl. 1):S8-S14.
34. Tam C.C., Rodrigues L.C., Viviani L., Dodds J.P., Evans M.R., Hunter P.R., et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012, 61:69-77.
35. Haagsma J.A., Van Der Zanden B.P., Tariq L., van Pelt W., van Duynhoven Y.T.P.H., Havelaar A.H. Disease burden and costs of selected foodborne pathogens in the Netherlands 2006, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
36. Haagsma J.A., Siersema P.D., De Wit N.J., Havelaar A.H. Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiol Infect 2010, 138:1650-1656.
37. Havelaar A.H., Van Duynhoven Y.T., Nauta M.J., Bouwknegt M., Heuvelink A.E., De Wit G.A., et al. Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiol Infect 2004, 132:467-484.
38. Cassini A.M.K., Emborg H.D., Simonsen J., Teunis P., van Pelt W., Takkinen J. Estimation of incidence of symptomatic Salmonella and Campylobacter infections based on sero-incidence in 13 European countries. European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) 2015, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
39. ECDC seroincidence R package [software application] 2015, European Centre for Disease Prevention and Control, Stockholm. 1.0.4 ed.
40. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards) Scientific opinion on the development of a risk ranking toolbox for the EFSA BIOHAZ Panel. EFSA J 2015, 1:131.
41. van Lier A., McDonald S.A., Bouwknegt M., group E.P.I., Kretzschmar M.E., Havelaar A.H., et al. Disease burden of 32 infectious diseases in the Netherlands, 2007-2011. PLOS ONE 2016, 11:e0153106.
42. Plass D., Mangen M.J., Kraemer A., Pinheiro P., Gilsdorf A., Krause G., et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect 2014, 142:2024-2035.
43. Mangen M.-J., Havelaar A.H., Haagsma J.A., Kretzschmar M.E.E. The burden of Campylobacter-associated disease in six European countries. Microb Risk Anal 2016.
44. Kwong J.C., Ratnasingham S., Campitelli M.A., Daneman N., Deeks S.L., Manuel D.G., et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS ONE 2012, 7:e44103.
45. Havelaar A.H., Kirk M.D., Torgerson P.R., Gibb H.J., Hald T., Lake R.J., et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med 2015, 12:e1001923.
46. Devleesschauwer B., Haagsma J.A., Angulo F.J., Bellinger D.C., Cole D., Dopfer D., et al. Methodological framework for World Health Organization estimates of the global burden of foodborne disease. PLOS ONE 2015, 10:e0142498.
47. Kirk M.D., Pires S.M., Black R.E., Caipo M., Crump J.A., Devleesschauwer B., et al. Correction: World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med 2015, 12:e1001940.
48. Pires S.M., Fischer-Walker C.L., Lanata C.F., Devleesschauwer B., Hall A.J., Kirk M.D., et al. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food. PLOS ONE 2015, 10:e0142927.
49. Majowicz S.E., Scallan E., Jones-Bitton A., Sargeant J.M., Stapleton J., Angulo F.J., et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis 2014, 11:447-455.
50. Hald T., Aspinall W., Devleesschauwer B., Cooke R., Corrigan T., Havelaar A.H., et al. World Health Organization estimates of the relative contributions of food to the burden of disease due to selected foodborne hazards: a structured expert elicitation. PLOS ONE 2016, 11:e0145839.
51. (BIOHAZ) EPoBH Scientific opinion on quantification of the risk posed by broiler meat to human campylobacteriosis in the EU. EFSA J 2010, 8:89.
52. EFSA Panels on Biological Hazards (BIOHAZ) oCitFCC, and on Animal Health and Welfare (AHAW) Scientific opinion on the public health hazards to be covered by inspection of meat (poultry). EFSA J 2012, 10:179.
53. Dahl V., Tegnell A., Wallensten A. Communicable diseases prioritized according to their public health relevance, Sweden, 2013. PLOS ONE 2015, 10:e0136353.
54. Balabanova Y., Gilsdorf A., Buda S., Burger R., Eckmanns T., Gartner B., et al. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS ONE 2011, 6:e25691.
55. European Centre for Disease Prevention and Control (ECDC) Best practices in ranking emerging infectious disease threats 2015, ECDC, Stockholm.
56. Marsh K., Dolan P., Kempster J., Lugon M. Prioritizing investments in public health: a multi-criteria decision analysis. J Public Health 2013, 35:460-466.
57. Bouwknegt M., Neslo H.A., de Roda HusmanAM R., Hogerwerf L., van Steenbergen J., et al. Ranking infectious disease risks to support preparedness prioritization in the European Union. European Public Health Conference 2015.